Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is a non-invasive diagnostic tool with superior accuracy over conventional imaging in studying prostate cancer (PCa) [1]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.